Skip to main content
Erschienen in: Cancer Causes & Control 11/2012

01.11.2012 | Original paper

Understanding disparities in leukemia: a national study

verfasst von: M. I. Patel, Y. Ma, B. S. Mitchell, K. F. Rhoads

Erschienen in: Cancer Causes & Control | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Disparities in solid tumors have been well studied. However, disparities in hematologic malignancies have been relatively unexplored on population-based levels. The purpose of this study is to examine the relationship between race/ethnicity and acute leukemia mortality.

Methods

All patients with acute leukemia [acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML)] were identified in the Surveillance Epidemiology and End Results database, 1999–2008. Kaplan–Meier curves were generated to reflect survival probabilities by race/ethnicity. Multivariable Cox proportional hazard models estimated hazard of mortality by race with adjustment for individual (age, gender, year of diagnosis) and select genetic factors.

Results

A total of 39,002 patients with acute leukemia were included in the study. Overall, there was a mortality disparity in acute leukemia for blacks (HR 1.17, p < 0.0001) and Hispanics (HR 1.13, p < 0.0001) compared with non-Hispanic whites. In stratified analysis, disparities in ALL were greater than AML; blacks (HR[ALL]1.45, p < 0.0001; HR[AML]1.12, p < 0.0011); Hispanics (HR[ALL]1.46, p < 0.0001; HR[AML]1.06, p < 0.0001). Adjustment for individual patient and select genetic factors did not explain disparities.

Conclusions

Blacks and Hispanics suffer decreased survival in acute leukemia as compared to others. Further investigation is needed to understand the drivers of poor cancer outcomes in these populations.
Literatur
3.
Zurück zum Zitat White A, Vernon SW, Franzini L et al (2011) Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer 116:4622–4631CrossRef White A, Vernon SW, Franzini L et al (2011) Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer 116:4622–4631CrossRef
4.
Zurück zum Zitat Vainshtein J (2008) Disparities in breast cancer incidence across racial/ethnic strata and socioeconomic status: a systematic review. J Natl Med Assoc 100:833–839PubMed Vainshtein J (2008) Disparities in breast cancer incidence across racial/ethnic strata and socioeconomic status: a systematic review. J Natl Med Assoc 100:833–839PubMed
5.
Zurück zum Zitat Underwood JM, Townsend JS, Tai E et al. (2011).Racial and regional disparities in lung cancer incidence. Cancer Underwood JM, Townsend JS, Tai E et al. (2011).Racial and regional disparities in lung cancer incidence. Cancer
6.
Zurück zum Zitat Rubnitz JE, Lensing S, Razzouk BI et al (2007) Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience. Pediatr Blood Cancer 48:10–15PubMedCrossRef Rubnitz JE, Lensing S, Razzouk BI et al (2007) Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience. Pediatr Blood Cancer 48:10–15PubMedCrossRef
7.
Zurück zum Zitat Kadan-Lottick NS, Ness KK, Bhatia S et al (2003) Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290:2008–2014PubMedCrossRef Kadan-Lottick NS, Ness KK, Bhatia S et al (2003) Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290:2008–2014PubMedCrossRef
8.
Zurück zum Zitat Foucar K, Duncan MH, Stidley CA et al (1991) Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986). Cancer 67:2125–2130PubMedCrossRef Foucar K, Duncan MH, Stidley CA et al (1991) Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986). Cancer 67:2125–2130PubMedCrossRef
9.
Zurück zum Zitat Bhatia S, Sather HN, Heerema NA et al (2002) Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100:1957–1964PubMedCrossRef Bhatia S, Sather HN, Heerema NA et al (2002) Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100:1957–1964PubMedCrossRef
10.
Zurück zum Zitat Kent EE, Sender LS, Largent JA et al (2009) Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors. Cancer Causes Control 20:1409–1420PubMedCrossRef Kent EE, Sender LS, Largent JA et al (2009) Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors. Cancer Causes Control 20:1409–1420PubMedCrossRef
11.
Zurück zum Zitat Aplenc R, Alonzo TA, Gerbing RB et al (2006) Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children’s Oncology Group. Blood 108:74–80PubMedCrossRef Aplenc R, Alonzo TA, Gerbing RB et al (2006) Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children’s Oncology Group. Blood 108:74–80PubMedCrossRef
12.
Zurück zum Zitat Goggins WB, Lo FF (2012) Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database: 1988–2008. Cancer Causes Control 23:737–743PubMedCrossRef Goggins WB, Lo FF (2012) Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database: 1988–2008. Cancer Causes Control 23:737–743PubMedCrossRef
13.
Zurück zum Zitat Pullarkat ST, Danley K, Bernstein L et al (2009) High lifetime incidence of adult acute lymphoblastic leukemia among Hispanics in California. Cancer Epidemiol Biomarkers Prev 18:611–615PubMedCrossRef Pullarkat ST, Danley K, Bernstein L et al (2009) High lifetime incidence of adult acute lymphoblastic leukemia among Hispanics in California. Cancer Epidemiol Biomarkers Prev 18:611–615PubMedCrossRef
14.
Zurück zum Zitat Sekeres MA, Peterson B, Dodge RK et al (2004) Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood 103:4036–4042PubMedCrossRef Sekeres MA, Peterson B, Dodge RK et al (2004) Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood 103:4036–4042PubMedCrossRef
15.
Zurück zum Zitat Rodriguez CP, Baz R, Jawde RA et al (2008) Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia. Leuk Res 32:413–420PubMedCrossRef Rodriguez CP, Baz R, Jawde RA et al (2008) Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia. Leuk Res 32:413–420PubMedCrossRef
16.
Zurück zum Zitat Byrne MM, Halman LJ, Koniaris LG et al (2011) Effects of poverty and race on outcomes in acute myeloid leukemia. Am J Clin Oncol 34:297–304PubMedCrossRef Byrne MM, Halman LJ, Koniaris LG et al (2011) Effects of poverty and race on outcomes in acute myeloid leukemia. Am J Clin Oncol 34:297–304PubMedCrossRef
17.
Zurück zum Zitat Bradley CJ, Dahman B, Jin Y, et al. (2011) Acute myeloid leukemia: How the Uninsured Fare. Cancer Bradley CJ, Dahman B, Jin Y, et al. (2011) Acute myeloid leukemia: How the Uninsured Fare. Cancer
18.
Zurück zum Zitat Brady AK, Fu AZ, Earl M et al (2011) Race and intensity of post-remission therapy in acute myeloid leukemia. Leuk Res 35:346–350PubMedCrossRef Brady AK, Fu AZ, Earl M et al (2011) Race and intensity of post-remission therapy in acute myeloid leukemia. Leuk Res 35:346–350PubMedCrossRef
19.
Zurück zum Zitat Pulte D, Gondos A, Brenner H (2008) Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 93:594–600PubMedCrossRef Pulte D, Gondos A, Brenner H (2008) Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 93:594–600PubMedCrossRef
22.
Zurück zum Zitat Gray GE, Henderson BE, Pike MC (1980) Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst 64:461–463PubMed Gray GE, Henderson BE, Pike MC (1980) Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst 64:461–463PubMed
23.
Zurück zum Zitat Wilkinson JD, Fleming LE, MacKinnon J et al (2001) Lymphoma and lymphoid leukemia incidence in Florida children: ethnic and racial distribution. Cancer 91:1402–1408PubMedCrossRef Wilkinson JD, Fleming LE, MacKinnon J et al (2001) Lymphoma and lymphoid leukemia incidence in Florida children: ethnic and racial distribution. Cancer 91:1402–1408PubMedCrossRef
24.
Zurück zum Zitat Zak Y, Rhoads KF, Visser BC (2011) Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type. Arch Surg 146:778–784PubMedCrossRef Zak Y, Rhoads KF, Visser BC (2011) Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type. Arch Surg 146:778–784PubMedCrossRef
25.
Zurück zum Zitat Rhoads KF, Cullen J, Ngo JV et al. (2011) Racial and ethnic differences in lymph node examination after colon cancer resection do not completely explain disparities in mortality. Cancer Rhoads KF, Cullen J, Ngo JV et al. (2011) Racial and ethnic differences in lymph node examination after colon cancer resection do not completely explain disparities in mortality. Cancer
26.
Zurück zum Zitat Caligiuri MA, Stout MP, Gilliland DG (1997) Molecular biology of acute myeloid leukemia. Semin Oncol 24:32–44 Caligiuri MA, Stout MP, Gilliland DG (1997) Molecular biology of acute myeloid leukemia. Semin Oncol 24:32–44
28.
Zurück zum Zitat Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK (1998) World Health Organization classification of lymphomas: a work in progress. Ann Oncol 9(Suppl 5):S25–S330PubMedCrossRef Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK (1998) World Health Organization classification of lymphomas: a work in progress. Ann Oncol 9(Suppl 5):S25–S330PubMedCrossRef
Metadaten
Titel
Understanding disparities in leukemia: a national study
verfasst von
M. I. Patel
Y. Ma
B. S. Mitchell
K. F. Rhoads
Publikationsdatum
01.11.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 11/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0062-3

Weitere Artikel der Ausgabe 11/2012

Cancer Causes & Control 11/2012 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.